NCT05177770 2025-05-08Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate CancerCoherus Oncology, Inc.Phase 2 Terminated16 enrolled 10 charts
NCT04747470 2024-09-03Study to Assess the Effects of GS-3583 in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Terminated13 enrolled 18 charts